Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6827536 | Schizophrenia Research | 2011 | 6 Pages |
Abstract
Neurocognitive deficits were pronounced in this cross-diagnostic sample of patients with psychotic disorders, and did not differ by diagnosis. Neurocognitive dysfunction may represent a symptom dimension that spans diagnostic categories, and may reflect shared pathogenic processes. As neurocognitive dysfunction is among the strongest predictors of outcome in patients, efforts to treat these deficits, which have shown promise in schizophrenia, should be extended to all patients with psychosis.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Kathryn E. Lewandowski, Bruce M. Cohen, Matcheri S. Keshavan, Dost Ãngür,